2020. Benefit of using renal sodium-glucose cotransporter inhibitors 2 (iSGLT-2) in patients with type 2 Diabetes Mellitus and Heart Failure. Electronic Journal Collection Health. 12, 9 (Sep. 2020), e4349. DOI:https://doi.org/10.25248/reas.e4349.2020.